He and his wife, Tia, are working hard to offer the same hope to others with his rare condition, as they advocate for newborn ...

4D-310 is under development for the treatment of Fabry disease. The drug candidate is administered through intravenous route. The drug candidate is based on vector evolution platform technology that ...

Amicus Therapeutics' shares are down 15% recently despite a profitable Q3 2024 and raised FY2024 outlook. Click here to find ...

Major positive events in 2024 include India’s first solar-powered remote village, the discovery of plastic-decomposing worms, ...